Literature DB >> 16410145

Structural analysis of the human neuroblastoma DNA replication complex: insights into faulty proliferation.

John A Sandoval1, Jay L Grosfeld, Robert J Hickey, Linda H Malkas.   

Abstract

BACKGROUND: Whether faulty DNA synthesis contributes to neuroblastoma (NB) pathogenesis has received little attention. We have shown that NB DNA replication is orchestrated by a multiprotein DNA replication complex (DNA synthesome) which mediates error-prone DNA synthesis. We sought to define proteomic alterations of the NB DNA synthesome, which lead to lowered replication fidelity.
METHODS: DNA synthesomes from NB and neural stem (NS) cell culture were purified. Proteomic differences of the DNA synthesome between NB and NS cells were determined using 2-dimensional polyacrylamide gel electrophoresis and immunodetection.
RESULTS: DNA synthesome proteins from NB and NS cells were compared. Only replication protein A (RPA) showed distinct changes. RPA from NS cells resolved as a single spot (isoelectric point [pI] 5.75), whereas RPA in NB showed a main spot (pI 5.75) along with 3 additional isoforms. RPA binds to single-stranded DNA and participates in protein-protein interactions.
CONCLUSIONS: NB DNA synthesome showed 3 distinct isoforms of RPA when compared with NS cells. These findings are significant in that it is possible to link changes in the fidelity of DNA replication with a specific protein alteration of the NB DNA synthetic apparatus. The novel RPA forms may be a new signature of NB malignancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410145     DOI: 10.1016/j.jpedsurg.2005.10.046

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Error-promoting DNA synthesis in ovarian cancer cells.

Authors:  Heqiao Dai; Robert J Hickey; Jianying Liu; Robert M Bigsby; Carita Lanner; Linda H Malkas
Journal:  Gynecol Oncol       Date:  2013-07-12       Impact factor: 5.482

2.  Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.

Authors:  Shanna J Smith; Robert J Hickey; Linda H Malkas
Journal:  Cancer Biol Ther       Date:  2016-02-18       Impact factor: 4.742

3.  Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.

Authors:  Robert G Lingeman; Robert J Hickey; Linda H Malkas
Journal:  Cancer Chemother Pharmacol       Date:  2014-09-05       Impact factor: 3.333

4.  Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis.

Authors:  Caroline M Li; Yunan Miao; Robert G Lingeman; Robert J Hickey; Linda H Malkas
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.